Showing 20,721 - 20,740 results of 102,951 for search '(( a web decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.07s Refine Results
  1. 20721
  2. 20722

    Image_2_SIRT1 haplo-insufficiency results in reduced cortical bone thickness, increased porosity and decreased estrogen receptor alpha in bone in adult 129/Sv female mice.tif by Hanna Artsi (777390)

    Published 2022
    “…</p>Discussion<p>These findings demonstrate that 50% reduction in SIRT1 is sufficient to induce the hallmarks of skeletal aging namely, decreased cortical thickness and increased porosity in female mice, highlighting the role of SIRT1 as a regulator of cortical bone quantity and quality. …”
  3. 20723

    Image_1_SIRT1 haplo-insufficiency results in reduced cortical bone thickness, increased porosity and decreased estrogen receptor alpha in bone in adult 129/Sv female mice.tif by Hanna Artsi (777390)

    Published 2022
    “…</p>Discussion<p>These findings demonstrate that 50% reduction in SIRT1 is sufficient to induce the hallmarks of skeletal aging namely, decreased cortical thickness and increased porosity in female mice, highlighting the role of SIRT1 as a regulator of cortical bone quantity and quality. …”
  4. 20724
  5. 20725
  6. 20726
  7. 20727
  8. 20728
  9. 20729

    Data_Sheet_1_Changes at a Critical Branchpoint in the Anthocyanin Biosynthetic Pathway Underlie the Blue to Orange Flower Color Transition in Lysimachia arvensis.zip by Mercedes Sánchez-Cabrera (10176290)

    Published 2021
    “…In particular, F3′5′H and DFR, two genes at a critical branchpoint in the ABP for determining flower color, showed differential expression. …”
  10. 20730

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  11. 20731

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  12. 20732

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  13. 20733

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  14. 20734

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  15. 20735

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  16. 20736
  17. 20737
  18. 20738

    A Ligand-Based Drug Design. Discovery of 4‑Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2 by Jiawang Liu (1330971)

    Published 2015
    “…With a 5 min preincubation in the presence of NADPH, 0.01 μM 7,8-furanoflavone completely inactivates P450 1A2 but does not influence the activities of P450s 1A1 and 1B1. …”
  19. 20739

    Changes in the SF change rate every 5 s in Experiment 1. by Hiroaki Furukawa (14341649)

    Published 2023
    “…Compared to no footsteps condition (NF), the step frequency seems to decrease in the +5 bpm (A) and -5 bpm (B) footsteps condition but there were no significant differences between these conditions.…”
  20. 20740